Post ‘Warfarin’ Competition, Who Will Win? ‘Xarelto’ may be? IMS Data Analysis since Last Year
Three major brands are having a mixed feeling of joy and sadness on the post ‘Warfarin’ competition which is happening 60 years after the launch of the‘Warfarin’.
New oral Anticoagulants called‘Xarelto’ (Bayer), ‘Pradaxa’ (Boeringer Ingelheim), and ‘Eliquis’ (BMS) are having a competition after ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
